Your browser doesn't support javascript.
loading
Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload.
Guo, Xinji; Kolpakov, Mikhail A; Hooshdaran, Bahman; Schappell, William; Wang, Tao; Eguchi, Satoru; Elliott, Katherine J; Tilley, Douglas G; Rao, A Koneti; Andrade-Gordon, Patricia; Bunce, Matthew; Madhu, Chintala; Houser, Steven R; Sabri, Abdelkarim.
Afiliación
  • Guo X; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Kolpakov MA; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Hooshdaran B; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Schappell W; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Wang T; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Eguchi S; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Elliott KJ; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Tilley DG; Center of Translational Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Rao AK; Sol Sherry Thrombosis Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Andrade-Gordon P; Janssen Pharmaceutical, Spring House, Pennsylvania.
  • Bunce M; Janssen Pharmaceutical, Spring House, Pennsylvania.
  • Madhu C; Janssen Pharmaceutical, Spring House, Pennsylvania.
  • Houser SR; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
  • Sabri A; Cardiovascular Research Center, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania.
JACC Basic Transl Sci ; 5(1): 69-83, 2020 Jan.
Article en En | MEDLINE | ID: mdl-32043021
ABSTRACT
Activated factor X is a key component of the coagulation cascade, but whether it directly regulates pathological cardiac remodeling is unclear. In mice subjected to pressure overload stress, cardiac factor X mRNA expression and activity increased concurrently with cardiac hypertrophy, fibrosis, inflammation and diastolic dysfunction, and responses blocked with a low coagulation-independent dose of rivaroxaban. In vitro, neurohormone stressors increased activated factor X expression in both cardiac myocytes and fibroblasts, resulting in activated factor X-mediated activation of protease-activated receptors and pro-hypertrophic and -fibrotic responses, respectively. Thus, inhibition of cardiac-expressed activated factor X could provide an effective therapy for the prevention of adverse cardiac remodeling in hypertensive patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Basic Transl Sci Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Basic Transl Sci Año: 2020 Tipo del documento: Article